ZERBAXA POWDER FOR SOLUTION FOR INJECTION 1G/0.5G
Product details
Registration number: SIN15317P
Classification: Prescription Only
Active ingredients:
- Ceftolozane Sulfate 1147mg eqv Ceftolozane
- Tazobactam Sodium 537mg eqv Tazobactam
Strength:
- 1000mg
- 500mg
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Registrant: MSD PHARMA (SINGAPORE) PTE. LTD.
ATC code: J01DI54
HSA approval date: 14 August 2017
Manufacturer(s):
- Steri-Pharma, LLC
- ACS Dobfar, S.p.A (ACSD2) (Ceftolozane Drug Product Intermediate)
Manufacturing country/countries: UNITED STATES; ITALY
What are the HSA registration number and classification for ZERBAXA POWDER FOR SOLUTION FOR INJECTION 1G/0.5G?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15317P
Classification: Prescription Only
What active ingredients and strength are recorded for ZERBAXA POWDER FOR SOLUTION FOR INJECTION 1G/0.5G?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Ceftolozane Sulfate 1147mg eqv Ceftolozane
- Tazobactam Sodium 537mg eqv Tazobactam
Strength:
- 1000mg
- 500mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ZERBAXA POWDER FOR SOLUTION FOR INJECTION 1G/0.5G?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for ZERBAXA POWDER FOR SOLUTION FOR INJECTION 1G/0.5G?
According to the HSA dataset updated 7 August 2026:
Registrant: MSD PHARMA (SINGAPORE) PTE. LTD.
Which manufacturers and countries are listed for ZERBAXA POWDER FOR SOLUTION FOR INJECTION 1G/0.5G?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Steri-Pharma, LLC
- ACS Dobfar, S.p.A (ACSD2) (Ceftolozane Drug Product Intermediate)
Manufacturing country/countries: UNITED STATES; ITALY
Where can I look up ZERBAXA POWDER FOR SOLUTION FOR INJECTION 1G/0.5G in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15317P or the exact product name ZERBAXA POWDER FOR SOLUTION FOR INJECTION 1G/0.5G. The general register link does not preselect this product.
What are the source dates for this ZERBAXA POWDER FOR SOLUTION FOR INJECTION 1G/0.5G record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ZERBAXA POWDER FOR SOLUTION FOR INJECTION 1G/0.5G record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15317P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)